| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Frances V O'Callaghan, Terry Hanno. Normalization of marijuana use: its effects on adolescents' intentions to use marijuana. Substance use & misuse. vol 38. issue 2. 2003-06-11. PMID:12625427. |
normalization of marijuana use: its effects on adolescents' intentions to use marijuana. |
2003-06-11 |
2023-08-12 |
Not clear |
| Levi Ross, Connie L Kohler, Diane M Grimley, Jeffrey Belli. Intention to use condoms among three low-income, urban African American subgroups: cocaine users, noncocaine drug users, and non-drug users. Journal of urban health : bulletin of the New York Academy of Medicine. vol 80. issue 1. 2003-06-05. PMID:12612104. |
cocaine use, marijuana use, alcohol use, and polysubstance use (e.g., alcohol and cocaine, alcohol and marijuana) are associated with high-risk sexual behavior and higher rates of sexually transmitted diseases (stds) and human immunodeficiency virus (hiv). |
2003-06-05 |
2023-08-12 |
human |
| Marvin Eisen, Gail L Zellman, Holly A Massett, David M Murra. Evaluating the Lions-Quest "Skills for Adolescence" drug education program: first-year behavior outcomes. Addictive behaviors. vol 27. issue 4. 2003-05-16. PMID:12188596. |
for baseline users, there were three significant sfa delays in transition to experimental or recent use of more "advanced" substances: drinking to smoking, drinking to marijuana use, and binge drinking to marijuana. |
2003-05-16 |
2023-08-12 |
Not clear |
| Albert D Fraser, David Wort. Monitoring urinary excretion of cannabinoids by fluorescence-polarization immunoassay: a cannabinoid-to-creatinine ratio study. Therapeutic drug monitoring. vol 24. issue 6. 2003-05-07. PMID:12451292. |
the objective of this study was to determine whether a semiquantitative cannabinoids immunoassay (corrected for creatinine concentration) could differentiate new marijuana use from residual cannabinoid excretion in chronic users of marijuana or hashish compared with gc-ms. |
2003-05-07 |
2023-08-12 |
human |
| Albert D Fraser, David Wort. Monitoring urinary excretion of cannabinoids by fluorescence-polarization immunoassay: a cannabinoid-to-creatinine ratio study. Therapeutic drug monitoring. vol 24. issue 6. 2003-05-07. PMID:12451292. |
the authors conclude that fpia cannabinoid analysis should be further evaluated as an alternative to gc-ms quantitation to help distinguish new marijuana use from residual marijuana metabolite excretion in clinical drug treatment programs. |
2003-05-07 |
2023-08-12 |
human |
| Albert D Fraser, Lawrence Coffin, David Wort. Drug and chemical metabolites in clinical toxicology investigations: the importance of ethylene glycol, methanol and cannabinoid metabolite analyses. Clinical biochemistry. vol 35. issue 7. 2003-04-02. PMID:12493577. |
the second objective is to demonstrate that creatinine corrected urine specimens positive for cannabinoids may help differentiate new marijuana use from the excretion of residual delta(9) -thc-cooh in chronic users of marijuana or hashish. |
2003-04-02 |
2023-08-12 |
human |
| Jag H Khalsa, Sander Genser, Henry Francis, Billy Marti. Clinical consequences of marijuana. Journal of clinical pharmacology. vol 42. issue S1. 2003-03-12. PMID:12412830. |
research presented in this special supplement will show that in addition to marijuana abuse/dependence, marijuana use is associated in some studies with impairment of cognitive function in the young and old, fetal and developmental consequences, cardiovascular effects (heart rate and blood pressure changes), respiratory/pulmonary complications such as chronic cough and emphysema, impaired immune function leading to vulnerability to and increased infections, and the risk of developing head, neck, and/or lung cancer. |
2003-03-12 |
2023-08-12 |
Not clear |
| Aron H Lichtman, Billy R Marti. Marijuana withdrawal syndrome in the animal model. Journal of clinical pharmacology. vol 42. issue S1. 2003-03-12. PMID:12412832. |
although the proposition that repeated marijuana use can lead to marijuana dependence has long been accepted, only recently has evidence emerged suggesting that abstinence leads to clinically significant withdrawal symptoms. |
2003-03-12 |
2023-08-12 |
human |
| Stephen Sidne. Cardiovascular consequences of marijuana use. Journal of clinical pharmacology. vol 42. issue S1. 2003-03-12. PMID:12412838. |
however, acute effects of marijuana use include a decrease of the time until the onset of chest pain in patients with angina pectoris; one study has shown that marijuana may trigger the onset of myocardial infarction. |
2003-03-12 |
2023-08-12 |
human |
| Stephen Sidne. Cardiovascular consequences of marijuana use. Journal of clinical pharmacology. vol 42. issue S1. 2003-03-12. PMID:12412838. |
research directions might include more studies of cardiovascular disease outcomes and relationships of marijuana with cardiovascular risk factors, studies of metabolic and physiologic effects of chronic marijuana use that may affect cardiovascular disease risk, increased understanding of the role of the cannabinoid receptor system in cardiovascular regulation, and studies to determine if there is a therapeutic role for cannabinoids in blood pressure control or for neuroprotection after stroke. |
2003-03-12 |
2023-08-12 |
human |
| Todd T Brown, Adrian S Dob. Endocrine effects of marijuana. Journal of clinical pharmacology. vol 42. issue S1. 2003-03-12. PMID:12412841. |
in the 35 years since the active compound of marijuana, delta9-tetrahydrocannabinol, was isolated, the psychological and physiological impact of marijuana use has been actively investigated. |
2003-03-12 |
2023-08-12 |
Not clear |
| H Westley Clark, Arthur MacNeill Horton, Michael Dennis, Thomas F Babo. Moving from research to practice just in time: the treatment of cannabis use disorders comes of age. Addiction (Abingdon, England). vol 97 Suppl 1. 2003-02-03. PMID:12460124. |
this supplement issue on the treatment of marijuana use disorders describes two large multi-site field experiments: the cannabis youth treatment (cyt) study with adolescents and the marijuana treatment project (mtp) with adults. |
2003-02-03 |
2023-08-12 |
Not clear |
| Guy Diamond, Susan H Godley, Howard A Liddle, Susan Sampl, Charles Webb, Frank M Tims, Robert Meyer. Five outpatient treatment models for adolescent marijuana use: a description of the Cannabis Youth Treatment Interventions. Addiction (Abingdon, England). vol 97 Suppl 1. 2003-02-03. PMID:12460130. |
five outpatient treatment models for adolescent marijuana use: a description of the cannabis youth treatment interventions. |
2003-02-03 |
2023-08-12 |
Not clear |
| K I Bolla, K Brown, D Eldreth, K Tate, J L Cade. Dose-related neurocognitive effects of marijuana use. Neurology. vol 59. issue 9. 2002-12-09. PMID:12427880. |
although about 7 million people in the us population use marijuana at least weekly, there is a paucity of scientific data on persistent neurocognitive effects of marijuana use. |
2002-12-09 |
2023-08-12 |
Not clear |
| Daniel E Ford, Hong Thi Vu, James C Anthon. Marijuana use and cessation of tobacco smoking in adults from a community sample. Drug and alcohol dependence. vol 67. issue 3. 2002-10-22. PMID:12127195. |
clinicians working with patients who are trying to stop tobacco smoking may be aided by routinely assessing marijuana use history, particularly with the recent increase in co-smoking of marijuana and tobacco. |
2002-10-22 |
2023-08-12 |
Not clear |
| Diane M Morrison, Seana Golder, Thomas E Keller, Mary Rogers Gillmor. The theory of reasoned action as a model of marijuana use: tests of implicit assumptions and applicability to high-risk young women. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. vol 16. issue 3. 2002-10-16. PMID:12236456. |
prior marijuana use was only partially mediated by the tra variables; it also was directly related to intentions to use marijuana and to subsequent use. |
2002-10-16 |
2023-08-12 |
Not clear |
| Holly C Wilcox, Fernando A Wagner, James C Anthon. Exposure opportunity as a mechanism linking youth marijuana use to hallucinogen use. Drug and alcohol dependence. vol 66. issue 2. 2002-07-02. PMID:11906800. |
lsd), with a specific focus on the idea that two separate mechanisms might link marijuana use to hallucinogen use: (1) greater hallucinogen exposure opportunity for marijuana users versus nonusers; (2) increased probability of hallucinogen use for marijuana users versus nonusers, once the opportunity to use hallucinogens has occurred. |
2002-07-02 |
2023-08-12 |
human |
| Fernando A Wagner, James C Anthon. Into the world of illegal drug use: exposure opportunity and other mechanisms linking the use of alcohol, tobacco, marijuana, and cocaine. American journal of epidemiology. vol 155. issue 10. 2002-06-04. PMID:11994231. |
among young people with a cocaine opportunity, those who had used marijuana were more likely to use cocaine than were those with no history of marijuana use. |
2002-06-04 |
2023-08-12 |
Not clear |
| J E Manno, B R Manno, P M Kemp, D D Alford, I K Abukhalaf, M E McWilliams, F N Hagaman, M J Fitzgeral. Temporal indication of marijuana use can be estimated from plasma and urine concentrations of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid. Journal of analytical toxicology. vol 25. issue 7. 2002-02-28. PMID:11599597. |
to determine if a temporal relationship between marijuana use and metabolite excretion patterns could be established, eight healthy user-volunteers (18-35 years old) smoked marijuana cigarettes containing 0% (placebo), 1.77%, and 3.58% delta9-tetrahydrocannabinol (thc). |
2002-02-28 |
2023-08-12 |
human |
| J E Manno, B R Manno, P M Kemp, D D Alford, I K Abukhalaf, M E McWilliams, F N Hagaman, M J Fitzgeral. Temporal indication of marijuana use can be estimated from plasma and urine concentrations of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid. Journal of analytical toxicology. vol 25. issue 7. 2002-02-28. PMID:11599597. |
mathematical models proposed for determination of recent marijuana use were applied to data from this study and verified the temporal use of marijuana. |
2002-02-28 |
2023-08-12 |
human |